Evidence map›Paper›PMID 33304228›Full record

ArticleEngineering in life sciences2020

Immobilization of an amino acid racemase for application in crystallization-based chiral resolutions of asparagine monohydrate.

Thiane Carneiro, Katarzyna Wrzosek, Katja Bettenbrock, Heike Lorenz, Andreas Seidel-Morgenstern

Open access · goldAbstract read
In one paragraph

Article in Engineering in life sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Thiane CarneiroMax Planck Institute for Dynamics of Complex Technical Systems Magdeburg Germany.ORCID https://orcid.org/0000-0002-9752-9490
Katarzyna WrzosekMax Planck Institute for Dynamics of Complex Technical Systems Magdeburg Germany.
Katja BettenbrockMax Planck Institute for Dynamics of Complex Technical Systems Magdeburg Germany.
Heike LorenzMax Planck Institute for Dynamics of Complex Technical Systems Magdeburg Germany.
Andreas Seidel-MorgensternMax Planck Institute for Dynamics of Complex Technical Systems Magdeburg Germany.
Max Planck Institute for Dynamics of Complex Technical Systems · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integration of racemization and a resolution process is an attractive way to overcome yield limitations in the production of pure chiral molecules. Preferential crystallization and other crystallization-based techniques usually produce low enantiomeric excess in solution, which is a constraint for coupling with racemization. We developed an enzymatic fixed bed reactor that can potentially overcome these unfavorable conditions and improve the overall yield of preferential crystallization. Enzyme immobilization strategies were investigated on covalent-binding supports. The amino acid racemase immobilized in Purolite ECR 8309F with a load of 35 mg-enzyme/g-support showed highest specific activity (approx. 500 U/g-support) and no loss in activity in reusability tests. Effects of substrate inhibition observed for the free enzyme were overcome after immobilization. A packed bed reactor with the immobilized racemase showed good performance in steady state operation processing low enantiomeric excess inlet. Kinetic parameters from batch reactor experiments can be successfully used for prediction of packed bed reactor performance. Full conversions could be achieved for residence times above 1.1 min. The results suggest the potential of the prepared racemase reactor to be combined with preferential crystallization to improve resolution of asparagine enantiomers.

Indexed as

amino acid racemaseenzyme immobilizationpacked bed reactorracemization

Identifiers

PMID33304228
PMCPMC7708953
OpenAlexW3082006206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.